Correlation Between Inflection Point and Dianthus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Inflection Point and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inflection Point and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inflection Point Acquisition and Dianthus Therapeutics, you can compare the effects of market volatilities on Inflection Point and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inflection Point with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inflection Point and Dianthus Therapeutics.

Diversification Opportunities for Inflection Point and Dianthus Therapeutics

-0.4

Correlation Coefficient

Inflection Point  Dianthus Therapeutics

Very good diversification

The 3 months correlation between Inflection and Dianthus is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Inflection Point Acquisition and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Inflection Point is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inflection Point Acquisition are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Inflection Point i.e., Inflection Point and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between Inflection Point and Dianthus Therapeutics

Assuming the 90 days horizon Inflection Point Acquisition is expected to generate 1.55 times more return on investment than Dianthus Therapeutics. However, Inflection Point is 1.55 times more volatile than Dianthus Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about 0.22 per unit of risk. If you would invest  1,086  in Inflection Point Acquisition on September 22, 2024 and sell it today you would earn a total of  249.00  from holding Inflection Point Acquisition or generate 22.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Inflection Point Acquisition  vs.  Dianthus Therapeutics

Inflection Point Acq

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Inflection Point Acquisition are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Inflection Point unveiled solid returns over the last few months and may actually be approaching a breakup point.

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Inflection Point and Dianthus Therapeutics

The main advantage of trading using opposite Inflection Point and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inflection Point position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.

The idea behind Inflection Point Acquisition and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.